Results 81 to 90 of about 7,962 (210)
eLife, 2020 In pursuit of therapeutics for human polyomaviruses, we identified a peptide derived from the BK polyomavirus (BKV) minor structural proteins VP2/3 that is a potent inhibitor of BKV infection with no observable cellular toxicity.
Joshua R Kane +12 more
doaj +1 more source
BK virus‐associated urothelial carcinoma—A supra‐regional cohort of kidney transplant recipients
BJUI Compass, Volume 7, Issue 3, March 2026.Abstract Objectives This study aims to study the clinical features, pathological findings, and outcomes of BK virus‐associated urothelial carcinoma (UC) in kidney transplant recipients (KTRs). Patients and Methods The study was conducted in a retrospective cohort of KTRs with histologically confirmed UC managed at a UK supra‐regional transplant urology
Noah Beetge +4 more
wiley +1 more source
Evaluation of Polyomavirus BK infection in oncogenic patients
, 2019 <p>Polyomavirus BK, a double-stranded DNA virus, is a member of the Polyomaviridae family that is known to infect humans. Transmission of Polyomavirus BK occurs during childhood via oral or respiratory tracts.
Kariminik, A.
core +1 more source
VP‐1 quasispecies in human infection with polyomavirus BK [PDF]
Journal of Medical Virology, 2011 AbstractPolyomavirus BK is a recognized cause of nephropathy and hemorrhagic cystitis in kidney or allogeneic hematopoietic stem cell transplant recipients. This study explored a role of genetic variations in capsid protein VP‐1 gene as a factor in viral pathogenesis.
Luo, Chunqing +3 more
openaire +4 more sources
Pediatric Transplantation, Volume 30, Issue 3, March 2026.ABSTRACT Background Urothelial bladder carcinoma is extremely rare in children and its association with BK virus infection remains unclear. Methods We describe the case of an 11‐year‐old girl who developed a urothelial carcinoma of the bladder four years after receiving her first kidney transplant.
Martina Ichas +7 more
wiley +1 more source
, 2023 The immunohistochemistry of the patients with BK polyomavirus-associated nephropathy and the other conditions.
Motoko Yanagita (134965) +8 more
core +1 more source
Manufacturing and clinical applications of non‐CAR‐T immune effector cells
Transfusion, EarlyView.
Thane Kubik +2 more
wiley +1 more source
Transplant Infectious Disease, Volume 28, Issue 2, March/April 2026.Third‐party, BK virus‐specific cytotoxic T lymphocytes (CTLs) were safe and effective in reducing viremia in kidney and stem cell transplant recipients with BK virus nephropathy. However, they did not improve kidney function. Earlier administration may be more beneficial before nephropathy and irreversible damage occur.
Amanda Olson +18 more
wiley +1 more source
Electrochemical Biosensor for Rapid Detection of Acute Rejection in Kidney Transplants
Advanced Healthcare Materials, Volume 15, Issue 1, 9 January 2026.A low‐cost, rapid electrochemical immunosensor coated with a novel antifouling nanocomposite enables single‐step, dual‐biomarker profiling directly from unprocessed urine. Application in a clinical study shows accurate discrimination of acute rejection in kidney transplants from other acute kidney injuries via machine learning.
Rohit Gupta +9 more
wiley +1 more source
BK polyomavirus association with colorectal cancer development
Genetics and Molecular Research, 2016 The development of human neoplasms can be provoked by exposure to one of several viruses. Burkitt lymphoma, cervical carcinoma, and hepatocellular carcinoma are associated with Epstein-Barr, human papilloma, and hepatitis B virus infections, respectively.
M N, Khabaz +6 more
openaire +2 more sources